P244: COVID-19 vaccine does not increase the likelihood of disease exacerbation in IBD: results from a population-based studyECCO'22Year: 2022
Authors: Lev Zion, R.(1);Focht, G.(1);Lujan, R.(1);Mendelovici, A.(2);Friss, C.(1);Greenfeld, S.(3);Kariv, R.(4);Ben-Tov, A.(5,6);Matz, E.(7);Nevo, D.(8);Barak-Corren, Y.(9);Dotan, I.(10);Turner, D.(1);
(1)Shaare Zedek Medical Center, Department of Pediatric Gastroenterology, Jerusalem, Israel;(2)Shaare Zedek Medical Center, Department of Pediatric Gastroenterology, Jeusalem, Israel;(3)Maccabi Health Services and the Sackler Faculty of Medicine- Tel Aviv University, Medical Informatics, Tel-Aviv, Israel;(4)Maccabi Health Services and the Sackler Faculty of Medicine- Tel Aviv University, Gastroenterology, Tel-Aviv, Israel;(5)Maccabi Health Services and the Sackler Faculty of Medicine- Tel Aviv University, Institute for Research & Innovation, Tel-Aviv, Israel;(6)Dana-Dwek Children's Hospital- Tel-Aviv Sourasky Medical Center, Pediatric Gastroenterology, Tel-Aviv, Israel;(7)Leumit Health Services, Community Medicine, Tel-Aviv, Israel;(8)Tel-Aviv University, Department of Statistics and Operations Research, Tel-Aviv, Israel;(9)Boston Children's Hospital, Predictive Medicine Group, Boston, United States;(10)Rabin Medical Center and the Sackler Faculty of Medicine- Tel Aviv University, Gastroenterology, Petah Tikva, Israel;
P245: Dynemics of the Immune-transcriptome and Microbiome in Paediatric Inflammatory Bowel DiseaseECCO'22Year: 2022
Authors: Elawad, M.A.(1);Kumar, M.(2);Saadaui, M.(3);Elhag, D.(3);Akobeng, A.(2);Al-Mudahka, F.(2);Hendaus, M.(4);Al Khodor, S.(3);
(1)Sidra Medical and Research Centre, Department of Paediatric Gastroenterology, Doha, Qatar;(2)Sidra Medicine, Department of Paediatric Gastroenterology, Doha, Qatar;(3)Sidra Medicine, Research Department, Doha, Qatar;(4)Sidra Medicine, Pediatrics Department, Doha, Qatar;
P246: Persistent burden of disease in patients with Crohn’s disease treated with biologic therapy: results from a real-world survey in the United States (US), France, Germany, Italy, Spain, and United Kingdom (5EU)ECCO'22Year: 2022
Authors: Sikirica, M.(1);Lynch, J.(2);Kershaw, J.(3);Lukanova, R.(3);Baker, S.(3);Milligan, G.(3);
(1)Janssen, Market Access, Horsham, United States;(2)Janssen Research & Development- LLC, Immunology, Horsham, United States;(3)Adelphi Real World, Autoimmune, Bollington, United Kingdom;
P247: Comparison of discontinuation/switching between infliximab biosimilar and originator among Inflammatory Bowel Disease patients: a real-world analysis of two Canadian cohortsECCO'22Year: 2022
Authors: Moura, C.S.(1);Lukusa, L.(1);Wong, E.C.(2);Lakatos, P.L.(3);Afif, W.(3);Narula, N.(2);Bernatsky, S.(3);
(1)McGill University Health Centre, Centre for Outcomes Research and Evaluation, Montreal, Canada;(2)McMaster University, Department of Medicine Division of Gastroenterology, Hamilton, Canada;(3)McGill University, Department of Medicine, Montreal, Canada;
P248: Lifestyle changes after Inflamatory Bowel Disease diagnosis.ECCO'22Year: 2022
Authors: Belén Galipienso, O.(1);Cameo, J.(1);Bernabeu, P.(2);Mira, C.(1);García, M.D.M.(3);Pomares, C.(4);Muñoz, D.(5);Canales, N.(2);Gutierrez, A.(1);Zapater, P.(6);van-der Hofstadt, C.(2);Jover, R.(1);Ruiz, M.T.(7);Sempere, L.(1);
(1)General University Hospital-Alicante. ISABIAL., Gastroenterology Department, Alicante, Spain;(2)General University Hospital-Alicante. ISABIAL., Health Psychology Department, Alicante, Spain;(3)University Hospital-San Juan, Gastroenterology Department, Alicante, Spain;(4)General University Hospital-Elche, Gastroenterology Department, Elche, Spain;(5)University and Polytechnic La Fe Hospital, Gastroenterology Department, Valencia, Spain;(6)General University Hospital-Alicante. ISABIAL. CIBEREHD, Pharmacology Department, Alicante, Spain;(7)University of Alicante. CIBERESP., Public Health Department, Alicante, Spain;
P249: Serum calprotectin is useful to confirm Inflammatory Bowel Disease activity but is not effective to predict relapse.ECCO'22Year: 2022
Authors: Veyrard, P.(1);Roblin, X.(2);Mao, R.(3);Nancey, S.(4);waeckel, L.(5);Berger, A.E.(6);Williet, N.(7);Bastide, L.(7);Barrau, M.(7);tournier, Q.(7);Paul, S.(6);
(1)CHU SAINT-ETIENNE, gastro enterology, Saint-Priest-en-Jarez, France;(2)chu saint etienne, gastro enterology, Saint-Priest-en-Jarez, France;(3)Hospital of Sun Yat-sen University, Inflammation and immunity, guangzhou, China;(4)chu Lyon sud, Gastroenterology, Lyon, France;(5)chu st etienne, immunology, Saint etienne, France;(6)CHU Saint etienne, Immunology, Saint Etienne, France;(7)CHU saint etienne, Gastroenterology, Saint etienne, France;
P250: Clinical validation of a point of care test for fecal calprotectin in distinguishing irritable bowel syndrome from Inflammatory Bowel DiseaseECCO'22Year: 2022
Authors: Bray, K.(1);Bahur, B.(2);Yadav, M.(3);Skinner, M.(3);Wong, M.(3);Chon, K.(3);Huang, R.(3);Day, V.(3);Mimms, L.(3);Hale, M.(3);
(1)ProciseDx Inc., Clinical Development and Medical Affairs, San Diego, United States;(2)ProciseDx Inc., Clinical Operations, San Diego, United States;(3)ProciseDx Inc., Research and Development, San Diego, United States;
P251: Endoscopic and pathologic findings of the esophago-gastroduodenal involvement of Crohn’s disease in Korea: a prospective cohort studyECCO'22Year: 2022
Authors: Kim, G.H.(1);Kim, J.(2);Park, S.H.(1);Ahn, J.Y.(1);Ye, B.D.(1);Jung, H.Y.(1);Yang, S.K.(1);
(1)Asan Medical Center University of Ulsan College of Medicine, Gastroenterology, Seoul, Korea- Republic Of;(2)Asan Medical Center University of Ulsan College of Medicine, Pathology, Seoul, Korea- Republic Of;
P252: Low adherence is associated with worse disease course in Ulcerative Colitis: a retrospective study from a single referral center.ECCO'22Year: 2022
Authors: Viola, A.(1);Demarzo, M.G.(2);Abbruzzese, A.(1);Chiappetta, M.F.(1);Costantino, G.(1);Alibrandi, A.(3);Fries, W.(1);
(1)University of Messina., IBD-unit- Dept. of Clinical and Experimental Medicine., Messina, Italy;(2)University of Genoa- Ospedale Policlinico San Martino-IRCCS per l'Oncologia, Gastroenterology Unit- Department of Internal Medicine., Messina, Italy;(3)University of Messina., Department of Economics- Unit of Statistical and Mathematical Sciences, Messina, Italy;
P254: Crohn’s disease of the pouch: an overdiagnosed condition?ECCO'22Year: 2022
Authors: de Jong, D.C.(1);Reijntjes, M.(2);Wessels, E.(1);Buskens, C.(2);Hompes, R.(2);Löwenberg, M.(1);Gecse, K.(1);D'Haens, G.(1);Bemelman, W.(2);Duijvestein, M.(3);
(1)Amsterdam UMC- location AMC- The Netherlands, Department of Gastroenterology and Hepatology, Amsterdam, The Netherlands;(2)Amsterdam UMC- location AMC- The Netherlands, Department of Surgery, Amsterdam, The Netherlands;(3)Radboudumc, Department of Gastroenterology and Hepatology, Nijmegen, The Netherlands;
P255: Mirikizumab modulates genes associated with the symptom of bowel urgencyECCO'22Year: 2022
Authors: Krishnan, G.(1);Steere, B.(1);Higgs, R.(1);Wang, Y.C.(1);Harris, C.J.(1);Milch, C.(1);Escobar, R.(1);Reinisch, W.(2);Dubinsky, M.(3);
(1)Eli Lilly and Company, Biomedicines, Indianapolis, United States;(2)Medical University Vienna, Internal Medicine, Vienna, Austria;(3)Icahn School of Medicine at Mount Sinai, Mount Sinai, New York, United States;
P256: The practical use of an eHealth platform for inflammatory bowel disease patients: the validation of the IBD Tool web-based tele-monitoring systemECCO'22Year: 2022
Authors: Giuffrida, E.(1,2);Mangia, M.(1,3);Figini, V.(4);Carli, E.(1);Colombo, A.(1);Mendolaro, M.(1);Lavagna, A.(1);Lia, C.(5);Bonina, M.(5);Martínez De Carnero, F.(5);Morello, E.(1);Cosimato, M.(1);Rocca, R.(1);Pagna, G.(4,5);Daperno, M.(1);
(1)Mauriziano Hospital, Department of Gastroenterology and Endoscopy, Torino, Italy;(2)@Rodolico - S. Marco@ Policlinic Hospital, Gastroenterology Unit, Catania, Italy;(3)ASL TO4 Hospital, Gastroenterology Unit, Ciriè, Italy;(4)LINKS Foundation, LINKS Foundation, Turin, Italy;(5)Polytechnic of Turin, Polytechnic of Turin, Turin, Italy;
P257: The clinical decision support tool has low performance in predicting outcome to ustekinumab in Crohn’s diseaseECCO'22Year: 2022
Authors: Alsoud, D.(1);Sabino, J.(1,2);Ferrante, M.(1,2);Verstockt , B.(1,2);Vermeire, S.(1,2);
(1)KU Leuven, Translational Research in Gastrointestinal Disorders- Department of Chronic Disease- Metabolism and Ageing, Leuven, Belgium;(2)University Hospitals Leuven, Department of Gastroenterology and Hepatology, Leuven, Belgium;
P258: Impact of inflammatory bowel diseases on the phenotype and severity of primary sclerosing cholangitis - a systematic review with meta-analysisECCO'22Year: 2022
Authors: Attauabi, M.(1,2,3);Wewer, M.D.(1,3);Bendtsen, F.(1,3);Seidelin, J.B.(2);Burisch, J.(1,3);
(1)Copenhagen University Hospital- Hvidovre, Gastrounit- Medical Section, Hvidovre, Denmark;(2)Herlev Hospital- University of Copenhagen, Department of Gastroenterology and Hepatology, Herlev, Denmark;(3)University of Copenhagen- Hvidovre Hospital, Copenhagen Center for Inflammatory Bowel Disease in Children- Adolescents and Adults, Hvidovre, Denmark;
P259: Metabolic associated Liver Disease and sex as key factors of cardiovascular risk in Inflammatory Bowel DiseaseECCO'22Year: 2022
Authors: García Mateo, S.(1,2);Martínez-Domínguez, S.J.(1,2);Ballesta Martínez, S.(3);Espinosa Rueda, J.(3);Tejero Justes, C.(3);Aso Gonzalvo, M.C.(1);Gallego Llera, B.(1);Alfambra Cabreja, E.(1);Baptista, P.M.(2,4);Nocito Colón , M.M.L.(5);Gargallo-Puyuelo , C.J.(1,2);Gomollón, F.(1,6,7);
(1)University Hospital Lozano Blesa, IBD Unit, Zaragoza, Spain;(2)IIS Aragón, Digestive Diseases, Zaragoza, Spain;(3)University Hospital Lozano Blesa, Neurology Unit, Zaragoza, Spain;(4)CIBERehd, Liver Diseases, Madrid, Spain;(5)University Hospital Lozano Blesa, Inmunology Unit, Zaragoza, Spain;(6)University of Zaragoza, Faculty of Medicine, Zaragoza, Spain;(7)ISS Aragón, Digestive Diseases, Zaragoza, Spain;
P260: Autoimmune pancreatitis in patients with Inflammatory Bowel Disease: results from a multicentre ECCO CONFER cases seriesECCO'22Year: 2022
Authors: Eder, P.M.(1);Verstock, B.(2);Culver, E.(3);Dragoni, G.(4);Kredel, L.I.(5);de Paredes, A.G.G.(6);Kaniewska, M.(7);Leibovitzh, H.(8);Oracz, G.(9);Ribaldone, D.G.(10);Wypych, J.(11);Badaoui, A.(12);Rahier, J.F.(12);Bezzio, C.(13);Bossuyt, P.(14);Falloon, K.(15);Vozzo, C.F.(15);Jess, T.(16);Larsen, L.(17);Olensen, S.S.(18);Starzyńska, T.(19);Chaparro, M.(20);Dror, D.(21);Ellul , P.(22);Gromny, I.(23);Maciejewska, K.(7);Peleg, N.(24);Shitrit, A.B.G.(25);Szwed, Ł.(26);Talar-Wojnarowska, R.(27);Snir, Y.(28);Zittan, E.(29);Goren, I.(30);
(1)Poznan University of Medical Sciences, Department of Gastroenterology- Dietetics and Internal Medicine, Poznań, Poland;(2)University Hospitals Leuven- KU Leuven, Department of Gastroenterology and Hepatology. Department of Chronic Diseases and Metabolism., Leuven, Belgium;(3)John Radcliffe Hospital Oxford, Translational Gastroenterology Unit, Oxford, United Kingdom;(4)Careggi University Hospital, Department of Gastroenterology, Florence, Italy;(5)Charité-Universitätsmedizin Berlin, Division of Gastroenterology- Infectiology and Rheumatology- Medical Department, Berlin, Germany;(6)Hospital Universitario Ramon y Cajal. Universidad de Alcala. IRYCIS., Gastroenterology and Hepatology Department, Madrid, Spain;(7)Central Clinical Hospital of Ministry of Internal Affairs, Department of Internal Medicine and Gastroenterology with IBD Subdivision, Warsaw, Poland;(8)Temerty Faculty of Medicine- Mount Sinai Hospital- University of Toronto, Zane Cohen Centre for Digestive Diseases- Division of Gastroenterology & Hepatology, Toronto, Canada;(9)The Children’s Memorial Health Institute, Department of Gastroenterology- Hepatology- Feeding Disorder and Pediatrics, Warsaw, Poland;(10)University of Turin, Department of Medical Sciences, Turin, Italy;(11)Copernicus Hospital, Department of Gastroenterology- Surgery and Nutrition, Gdańsk, Poland;(12)Université Catholique de Louvain, Department of Gastroenterology- CHU UCL Namur, Yvoir, Belgium;(13)Rho Hospital, Gastroenterology Unit, Rho Milano, Italy;(14)Imelda General Hospital, Imelda GI Clinical Research Center, Bonheiden, Belgium;(15)Digestive Diseases and Surgery Institute- Cleveland Clinic, Department of Gastroenterology- Hepatology and Nutrition, Cleveland, United States;(16)Aalborg University, Center for Molecular Prediction of Inflammatory Bowel Disease- Department of Clinical Medicine, Aalborg, Denmark;(17)Aalborg University Hospital and Aalborg University, Department of Gastroenterology and Hepatology. Center for Molecular Prediction of Inflammatory Bowel Disease – PREDICT- Department of Clinical Medicine- The Faculty of Medicine., Aalborg, Denmark;(18)Aalborg University Hospital and Aalborg University, Centre for Pancreatic Diseases and Mech-Sense- Department of Gastroenterology and Hepatology. Department of Clinical Medicine, Aalborg, Denmark;(19)Pomeranian Medical University in Szczecin, Department of Gastroenterology, Szczecin, Poland;(20)Hospital Universitario de La Princesa- Instituto de Investigación Sanitaria Princesa IIS-IP, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBEREHD, Madrid, Spain;(21)Galilee Medical Center, Department of Gastroenterology, Nahariya, Israel;(22)Mater dei Hospital, Division of Gastroenterology, Msida, Malta;(23)Wroclaw Medical University, Department of Gastroenterology and Hepatology, Wrocław, Poland;(24)Rabin Medical Center, The Division of Gastroenterology, Petah Tikva, Israel;(25)The Hebrew University of Jerusalem- Shaare Zedek Medical Center, IBD MOM Unit- Digestive Diseases Institute, Jerusalem, Israel;(26)Private Gastroenterology Practice, Private Gastroenterology Practice, Nowy Dwór Mazowiecki, Poland;(27)Medical University of Lodz, Department of Digestive Tract Diseases, Łódź, Poland;(28)Rabin Medical Center- Beilinson Campus, Gastroenterology Division, Petah Tikva, Israel;(29)Emek Medical Center, Ellen and Pinchas Mamber Institute of Gastroenterology and Liver Diseases- IBD Unit, Afula, Israel;(30)Rabin Medical Center affiliated with Sackler Faculty of Medicine- Tel Aviv University IL. Lerner Research Institute- Cleveland Clinic US., Division of Gastroenterology IL. Department of Inflammation and Immunity US., Petah Tikva IL. Cleveland US., Israel;
P261: Burden of bowel urgency across specific treatment groups among Ulcerative Colitis patients – real world global study analysesECCO'22Year: 2022
Authors: Atreya, R.(1);Redondo, I.(2);Hill, J.(3);Streit, P.(4);Hartz, S.(5);Knight, H.(6);Barlow, S.(6);Hennessy, F.(6);Hunter, T.(7);
(1)University Hospital Erlangen- Friedrich-Alexander-University Erlangen-Nurnberg, Medical Department 1, Erlangen, Germany;(2)Eli Lilly and Company, International Medical, Lisbon, Portugal;(3)Eli Lilly and Company, International PRA, Bracknell, United Kingdom;(4)Eli Lilly and Company, Global PRA, Vernier, Switzerland;(5)Eli Lilly and Company, Global Patient Outcomes Real World Evidence, Bracknell, United Kingdom;(6)Adelphi Real World, Real World Evidence, Bollington, United Kingdom;(7)Eli Lilly and Company, Global Patient Outcomes Real World Evidence, Indianapolis, United States;
P262: Decreased infliximab trough levels (TLI) is a moderate predictor of loss of response to IFX in IBD patients.ECCO'22Year: 2022
Authors: Roblin, X.(1);Berger, A.E.(2);Bastide, L.(1);Tournier, Q.(1);Veyrard, P.(1);Paul, S.(2);
(1)CHU Saint Etienne - Hospital Nord, Department of Gastroenterology and Hepatology- Inserm- CIC1408, Saint Priest en Jarez, France;(2)CHU Saint Etienne - Hospital Nord, Immunology - Inserm- CIC1408, Saint Priest en Jarez, France;
P263: Very early onset Inflammatory Bowel Diseases: Review of the Genoa-Messina joint clinical experience. Clinical history: Part I.ECCO'22Year: 2022
Authors: Gramaglia, S.M.C.(1);Cucinotta, U.(1);Dipasquale, V.(1);Arrigo, S.(2);Gandullia, P.(2);Romano, C.(1);
(1)Pediatric Gastroenterology and Cystic Fibrosis Unit, Department of Human Pathology in Adulthood and Childhood @G. Barresi@- University of Messina, Messina, Italy;(2)Institute 'Giannina Gaslini'- Genoa- Italy, Pediatric Gastroenterology and Endoscopy Unit, Genova, Italy;
